Home

2011 World Stem Cell Report

Printer-friendly version
World Stem Cell Report 2011
World Stem Cell Report: 2012 | 2011 | 2010 | 2009

More than 26 articles and 176 pages of previously unpublished insight into the forefront of regenerative medicine.

The editors of the 2011 World Stem Cell Report invited more than 26 experts to share their views on regenerative medicine strategies in the regions of North and South America, Europe and the Asia Pacific region, where stem cell research is on the forefront the biomedical research and commercialization agenda. The report serves as a reference and guide to this diverse universe of organizations and networks that influence the success of our field.

The theme of the 2011 World Stem Cell Report is “Translational Regenerative Medicine: from Bench to Bedside.” The Report provides a worldwide perspective of the issues facing the stem cell community that influence how the field of stem cells and regenerative medicine develops. This edition includes discussions of science, international perspectives, commercialization, policy, law, ethics and advocacy.

The annual World Stem Cell Report is published as a supplement to Regenerative Medicine. Through a special arrangement with our publication partners, we are able to provide free access to the 2011 World Stem Cell Report.

2011 World Stem Cell Report Table of Contents

Research & Development

Sponsors & Advertisements
  • Research Spotlight: key advances of the year, as nominated by experts in the field
  • Clinical Trials Update
    Future Science Group, UK
  • Research Update: CNS
    Anthony Mathur, Bart's & The London, UK
  • Research Update: Soft tissue
    Kotaro Yoshimura, University of Tokyo, Japan
  • Research Update: Bone & cartilage
    Christian Jorgensen, INSERM, France
  • Research Update: Neurology
    Marcel Daadi, Stanford University, CA, USA
  • Interview: Trachea
    Paolo Macchiarini, Karolinska Institute, Sweden
  • Interview: GRNOPC1: World’s first ESC-derived clinical trial
    Jane Lebkowski, Geron, CA, USA

Industry, Commercialization & Collaboration

  • Industry spotlight: Business Development, Advances, Regulatory Approvals
    Dusko Ilic, King’s College, London, UK
  • Scale-up challenges
    David Williams, Loughborough University, UK
  • US Department of Defense collaborations
    Wendy Dean, Allied Technologies & Consulting, LLC in support of the Armed Forces Institute of Regenerative Medicine, MD, USA
  • Interview: Ruth McKernan, Pfizer, UK

Intellectual Property

  • Brüstle v. Greenpeace: what does this mean for stem cell IP?
    Alex Denoon, Lawford Davies Denoon, UK
  • Promoting justice in stem cell IP
    Debra Mathews, John Hopkins University, MD, USA & The Hinxton Group

Policy, Regulatory & Ethics

  • Meet the regulators
    EMA, UK & FDA, USA
  • Sherley v. Sebelius
    Neal Goldfarb, Butzel Long Tighe Patton, PLLC, WA, USA
  • Medicare coverage: engaging on evidence
    Louis B. Jacques, Centers for Medicare and Medical Services, MD, USA
  • Ceding ground: the social media imperative for stem cell science
    Geoff Lomax, California Institute for Regenerative Medicine, CA, USA

Advocacy & Education

  • Stem Cell Action
    Bernie Siegel, Genetics Policy Institute, FL, USA
  • You only get what you measure: the need for innovative stem cell advocacy
    Alan Jakimo, Sidley Austin, NY, USA & Alan Fernandez, Genetics Policy Institute, FL, USA
  • Interview: Jonathan Thomas, Chairman, California Institute of Regenerative Medicine, CA, USA

Global Perspectives

  • Global Update: USA
    Kirstin R Matthews, Rice University, TX, USA
  • Global Update: Canada
    Drew Lyall, Canadian Stem Cell Network, Canada
  • Global Update: Japan
    Doug Sipp, RIKEN Center, Japan
  • Global Update: Scotland
    Aidan Courtney, Roslin Cells, Scotland
  • Global Update: Germany
    Frank-Roman Lauter, Berlin-Brandenburg Center for Regenerative Therapies, Germany
  • Global Update: England & Wales
    Dusko Ilic, King’s College London, UK
  • Making stem cells count for global health
    Halla Thorsteinsdotter, Toronto University, Canada 

Contact Alan Fernandez to learn more: alan@genpol.org or call (650) 847-1640.